These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31060746)

  • 1. Does Oral or Topical Tranexamic Acid Control Bleeding From Epistaxis?
    Bridwell RE; April MD; Long B
    Ann Emerg Med; 2019 Aug; 74(2):300-302. PubMed ID: 31060746
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical tranexamic acid (TXA) for the management of a bleeding arteriovenous fistula.
    Eberle ML; Schechter-Perkins EM; Altawil Z
    Am J Emerg Med; 2020 Feb; 38(2):407.e5-407.e6. PubMed ID: 31685307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical application of tranexamic acid for the reduction of bleeding.
    Ker K; Beecher D; Roberts I
    Cochrane Database Syst Rev; 2013 Jul; (7):CD010562. PubMed ID: 23881695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical tranexamic acid for spontaneous epistaxis.
    Santander MJ; Rosenbaum A; Winter M
    Medwave; 2018 Dec; 18(8):e7372. PubMed ID: 30550535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of bleeding upper aerodigestive tract tumor-a novel approach with antifibrinolytic agent: case series and literature review.
    Low TH; Huang J; Reid C; Elliott M; Clark JR
    Laryngoscope; 2013 Oct; 123(10):2449-52. PubMed ID: 23553514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new and rapid method for epistaxis treatment using injectable form of tranexamic acid topically: a randomized controlled trial.
    Zahed R; Moharamzadeh P; Alizadeharasi S; Ghasemi A; Saeedi M
    Am J Emerg Med; 2013 Sep; 31(9):1389-92. PubMed ID: 23911102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic Acid for Epistaxis--A Promising Treatment That Deserves Further Study.
    Clinkard D; Barbic D
    CJEM; 2016 Jan; 18(1):72-3. PubMed ID: 26088087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is topical tranexamic acid a better alternative for selected cases of anterior epistaxis management in the ED?
    Hassen GW; Clemons P; Kaplun M; Kalantari H
    Am J Emerg Med; 2018 Apr; 36(4):734.e1-734.e2. PubMed ID: 29310981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epistaxis complicated by rivaroxaban managed with topical tranexamic acid.
    Utkewicz MD; Brunetti L; Awad NI
    Am J Emerg Med; 2015 Sep; 33(9):1329.e5-7. PubMed ID: 25895714
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of topical tranexamic acid in the management of idiopathic anterior epistaxis in adult patients in the emergency department.
    Logan JK; Pantle H
    Am J Health Syst Pharm; 2016 Nov; 73(21):1755-1759. PubMed ID: 27769971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel use of tranexamic acid to reduce the need for Nasal Packing in Epistaxis (NoPac) randomised controlled trial: research protocol.
    Reuben A; Appelboam A; Barton A; Vickery PJ; Body R; Hilton M; Coppell J; Ewings P
    BMJ Open; 2019 Feb; 9(2):e026882. PubMed ID: 30772866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Best evidence topic reports. BET 3: Topical intranasal tranexamic acid for spontaneous epistaxis.
    Hilton L; Reuben A
    Emerg Med J; 2014 May; 31(5):436-7. PubMed ID: 24846097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriate dose of tranexamic acid in the topical treatment of anterior epistaxis, 500 mg vs 1000 mg: A double-blind randomized controlled trial.
    Arikan C; Akyol PY
    Sci Prog; 2024; 107(4):368504241264993. PubMed ID: 39351623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a mucosal atomization device for local application of tranexamic acid in epistaxis.
    Heymer J; Schilling T; Räpple D
    Am J Emerg Med; 2018 Dec; 36(12):2327. PubMed ID: 29685357
    [No Abstract]   [Full Text] [Related]  

  • 15. Case report: use of topical tranexamic acid to stop localised bleeding.
    Noble S; Chitnis J
    Emerg Med J; 2013 Jun; 30(6):509-10. PubMed ID: 22833592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical Tranexamic Acid for the Treatment of Acute Epistaxis: A Systematic Review and Meta-analysis.
    Gottlieb M; DeMott JM; Peksa GD
    Ann Pharmacother; 2019 Jun; 53(6):652-657. PubMed ID: 30577703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BET 1: Intravenous tranexamic acid in the treatment of acute epistaxis.
    Fox H; Hunter F
    Emerg Med J; 2015 Dec; 32(12):969-70. PubMed ID: 26598634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia.
    Klepfish A; Berrebi A; Schattner A
    Arch Intern Med; 2001 Mar; 161(5):767. PubMed ID: 11231712
    [No Abstract]   [Full Text] [Related]  

  • 19. Intranasal tranexamic acid for the treatment of hereditary hemorrhagic telangiectasia: a case report and review of treatment options.
    Flanagan BA; Collins C; Parra S
    Cutis; 2012 Feb; 89(2):69-72. PubMed ID: 22474728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating Effectiveness of Nasal Compression With Tranexamic Acid Compared With Simple Nasal Compression and Merocel Packing: A Randomized Controlled Trial.
    Akkan S; Çorbacıoğlu ŞK; Aytar H; Emektar E; Dağar S; Çevik Y
    Ann Emerg Med; 2019 Jul; 74(1):72-78. PubMed ID: 31080025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.